Navigation Links
Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year
Date:5/13/2008

tiatives are on track. During the second half we expect our revenue growth rate to be mid-to-high single digits, gross profit to increase ten to twenty percent, and operating income as adjusted to increase well in excess of gross profit as we experience better operating expense leverage. These projections assume that we continue to see the robust pipeline of capital spending projects in North America that we see at this time," Soderberg concluded.

Other second quarter revenue highlights regarding Hill-Rom business segments:

-- North America Acute Care. Hill-Rom North America Acute Care revenue

increased $11.5 million, or 5.2 percent, to $230.9 million--including

$2.5 million of favorable exchange rate movements. Capital sales

increased 1.6 percent, or $2.5 million, due in part to the initial

shipments of our new TotalCare Connect(TM) and TotalCare Connect

Bariatric(TM) bed platforms in March. These platforms provide

differentiated connectivity and a user-friendly caregiver interface.

This growth, and strong sales increases in our maternity beds and

stretchers, was, for the most part, offset by competitive pressure on

our mid-acuity patient support systems and architectural products.

North America rental revenue increased by $9.0 million, or 15.5

percent, during the quarter. Therapy rental products in acute care

grew in excess of 25 percent, due to a strong influenza and pneumonia

season, sharply higher volumes from 2007 product launches in bariatric

and wound care products, and the impact of a recent sole-source GPO

contract win. Moveable medical equipment rentals continued to reflect

year-over-year declines, although at much more modest rates.

-- International and Surgical. Hill-Rom International and Surgical

capital and rental revenue increased $23.8 million, or 32.5 percent, to<
'/>"/>

SOURCE Hill-Rom Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Hill-Rom to Present at the Citi Healthcare Conference
2. Hill-Rom to Present at the Bank of America 2008 Health Care Conference
3. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Second Quarter Earnings Webcast
4. Hill-Roms NaviCare(R) WatchChild(R) Solution Provides Enhanced Information Technology Solutions for Obstetrical Care
5. Hill-Rom Holdings, Inc. Announces Completion of Separation of Hillenbrand Industries Creating Two Public Companies
6. Hillenbrand Releases Investor Roadshow Materials and Updated Financial Guidance Related to Separation Of Hill-Rom and Batesville Casket
7. Hill-Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill-Rom Products Using Nanotechnology
8. Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery
9. Hill-Rom Introduces Fashionable, Affordable Bed for Home and Post-Acute Care Patients
10. Hill-Rom Announces Singapore Will Be Site for Asia-Pacific Innovation Center
11. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...ON, July 24 /PRNewswire-FirstCall/ --, Key Highli... of expectations and is now,raising targets for th...oup,revenues(1) of GBP492m up 6%, bringing Group o...ar. Misys is executing on its strategy and enterin...ding a platform for growth., To view the Multimed...
(Date:7/23/2008)...N-SALEM, N.C. A study out of Wake Forest Universi...oom doctors are correctly identifying patients who...ests haven,t yet confirmed it. , The study used ...patients with heart attack symptoms who were admit...ipating U.S. centers. , The findings were relea...
(Date:7/23/2008)...ne of vaccines for Immigration and Naturalization ...Health, BALTIMORE, July 23 /PRNewswire/ -- New va...ing for an immigrant visa for entry into the U.S. ...ent residence. Applicants,must show proof of vacci...ecommended by the U.S. Advisory Committee on Immun...
(Date:7/23/2008)...ng varicose veins in scrotum boosts sperm count, m...24 (HealthDay News) -- A simple, minimally invasiv...tility and improve a couple,s chances of having a ...d varicocele, is a network of tangled blood vessel...tion of blood through the veins in the testicles. ...
Breaking Medicine News(10 mins):Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 2Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 3Health News:Misys Announces Preliminary Results for the Year Ended 31 May 2008 4Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2Health News:USCIS Tightens Vaccination Requirements 2Health News:Simple Procedure Improves Male Fertility 2Health News:Simple Procedure Improves Male Fertility 3
...University of California Board of Regents today ap...million toward the development of the first phase...lanning to build a 289-bed, integrated medical cen...cer patients on a 14.5-acre parcel, which is south...
...heme educating coaches and referees in the dangers...duction in the number of spinal injuries suffered ...is weeks BMJ. Spinal cord injuries, although rar... permanently disabling injuries and death in rugby...
...ntists from Australia and UK writing in the Lancet...p cut down the risks of mothers-to-be developing ...s of 31 trials involving more than 32,000 women fo...protective effect of this drug against pre-eclamps...
...ntists at the University of Virginia and the Medic...e that participates in the regulation of the body...n regulating metabolism. Their finding shows that...ich is regulated by the circadian clock in the org...
Other Medicine News:Health News:UC Regents Approve Fundraised Campaign for UCSF Medical Center at Mission Bay 2Health News:Innovative Education Scheme Sees Fewer Rugby Players Suffering Spinal Injuries 2Health News:Research Favors Aspirin In Prevention Of Pre-Eclampsia 2Health News:Clock Gene Plays Role in Weight Gain, Study Finds 2
(Date:7/22/2008)...y Demonstrates Feasibility and Efficacy of Treatin...iver Cancer, SAN FRANCISCO, and YONGIN-SI, South ... Francisco, CA and Ottawa, Ontario), and its South... that novel findings from,a Phase I clinical trial...rated that the product was well-tolerated and resu...
(Date:7/22/2008)...TH SAN FRANCISCO, Calif., July 22 /- ...t has completed patient enrollment,in its Phase 1/...ity and,ammonia scavenging effects of HPN-100 (for...ylbutyrate) in patients with urea cycle disorders,...lts in the fourth quarter,of this year., (Logo: ...
(Date:7/22/2008)...HIA ANTIPOLIS, France, July 22 /PRNewswire-FirstCa...unced it has successfully completed the,enrollment...ed hypertension,in two clinical pharmacology studi...nnounced timelines. These trials are designed to a...n comparison to ibuprofen and,naproxen, using the ...
(Date:7/21/2008)... YORK, July 21 /- Ari Kiev, M.D., pre... speaker at the upcoming conference Wall,Street Un...ement,s Guide to,Wall Street. The conference will ...errace, 267 Fifth Avenue in New York. The event is...d mid-cap life science companies to gain,better in...
Breaking Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3Coherent Inc to Webcast First Fiscal Quarter 2008 Results 9937 1Dave Perbix Named Vice President Occupational Health Sales and Marketing for Kaiser Permanente 9933 1Dave Perbix Named Vice President Occupational Health Sales and Marketing for Kaiser Permanente 9933 2Vapotherm 28R 29 Announces Validation of U S Patent 2694 1Vapotherm 28R 29 Announces Validation of U S Patent 2694 2Clinimetrics Celebrates 20th Anniversary in Contract Research Business 2690 1
...FirstCall/ -- Vical,Incorporated today announced t...d positive results following interim analysis of d... 3 trial of an,angiogenesis product candidate usin...ndings that the primary efficacy,endpoint in the t...ce and that there were no major safety concerns re...
...AMADEO, one of the,first studies to compare the p...ockers in hypertensive patients with,diabetic nep...f Hypertension, Milan. The results from this study...ignificantly greater extent,than losartan.(1) ...ss, Foothills Hospital,in Calgary, Canada said "T...
Other Medicine Technology:Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 2New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 3New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 4New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 5
Anti Gliadin IgA Enzyme Immunosay for quantitative determination of Gliadin-IgG antibodies in serum.
...igned as a high throughput primary or backup instr...r offers performance and reliability equal to or g...advanced technology of the AUTION JET AJ-4270 and ...ate results, limiting interference from elevated p...
Assay uses highly specific rabbit anti-estriol antibody reparation - negligible cross-reactivity with other estrogen metabolites. Excellent assay precision and reproducibility. Superior sensitivity
...rone Sulfate (E1S) is the most abundant circulatin... men [1,2]. Estrone Sulfate is a major metabolite ...fe in blood [2,3]. In premenopausal women, estrone...e and estradiol, rising gradually during the folli...
Medicine Products: